Codiak BioSciences is developing a proprietary pipeline of novel, targeted medicines for diseases with high unmet medical need using it’s broad platform for the delivery of macromolecules to diverse cells and tissues.

Our technology capitalizes on the unique properties of exosomes which have been shown to deliver nucleic acids, proteins, lipids and small molecules to various cell types. Codiak will build and expand upon the natural tropism of exosomes for delivery of payloads to specific cell and tissue types, to solve the challenges of delivering macromolecules across biological membranes.